Viking Global Investors’s Eli Lilly LLY Stock Holding History

Viking Global Investors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-416,918	Closed	-$325M	–	88
2025 Q2	$325M	Buy	+416,918	New	+$324M	0.94%	46
2024 Q4	–	Sell	-152,038	Closed	-$135M	–	94
2024 Q3	$135M	Buy	152,038 +7,863	+5%	+$7.07M	0.49%	54
2024 Q2	$131M	Buy	144,175 +9,567	+7%	+$7.65M	0.5%	49
2024 Q1	$105M	Sell	134,608 -4,120	-3%	-$2.93M	0.39%	52
2023 Q4	$80.9M	Buy	+138,728	New	+$81M	0.3%	61
2016 Q4	–	Sell	-6,092,264	Closed	-$489M	–	71
2016 Q3	$489M	Sell	6,092,264 -3,285,131	-35%	-$263M	2.11%	18
2016 Q2	$738M	Sell	9,377,395 -2,386,383	-20%	-$180M	3.14%	9
2016 Q1	$847M	Buy	+11,763,778	New	+$890M	3.73%	8
2015 Q2	–	Sell	-1,398,711	Closed	-$102M	–	64
2015 Q1	$102M	Buy	+1,398,711	New	+$99.6M	0.39%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Viking Global Investors's LLY Position: Q3 2025 in Review

Viking Global Investors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 416,918 shares — an estimated $325M sold.

Viking Global Investors first reported a position in LLY in Q1 2015 and held it in 9 quarters. The position peaked at $847M in Q1 2016. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

Viking Global Investors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
Viking Global Investors sold 416,918 Eli Lilly shares in Q3 2025, an estimated $325M.
Viking Global Investors first reported a position in Eli Lilly in Q1 2015 and held it in 9 quarters.
Viking Global Investors's Eli Lilly position peaked at $847M in Q1 2016.
3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Viking Global Investors's 13F filing for Q3 2025, filed 14 Nov 2025.